Geode Capital Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCR
BCM
JC
AG
WS
Geode Capital Management's MTCR Position: Q1 2023 in Review
Geode Capital Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 76,235 shares — an estimated $34K sold.
Geode Capital Management first reported a position in MTCR in Q4 2020 and held it in 9 quarters. The position peaked at $375K in Q4 2020. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.
- Geode Capital Management reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Geode Capital Management sold 76,235 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $34K.
- Geode Capital Management first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
- Geode Capital Management's Metacrine, Inc. Common Stock position peaked at $375K in Q4 2020.
- 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.